Consultant Haematologist at NuTH | Honorary Clinical Senior Lecturer at Newcastle University l Interest in cancer thrombosis | Part of a neurodiverse family
The use of patient-reported outcome measures (PROMs) ➡️opportunity to optimize patient-centered care.
- in this @isth SSC communication, we propose recommendations for use of PROMs during clinical follow-up of patients with venous #thrombosis#VTE
https://t.co/Vcx2fhkTRe
Immune checkpoint inhibitor has similar #VTE risk as traditional chemotherapy in this large propensity score weighted analysis.
https://t.co/IJUo4hfPc0
Long-term outcome of DOACs & warfarin in CTEPH pts remain unclear. The
investigators in the Japanese prospective nationwide CTEPH registry revealed
that DOACs are as effective as warfarin with a lower risk of clinically relevant
bleeding.
@CTEPH_Registry
https://t.co/wORUC5ltui
New paper alert 📣
Autistic SPACE: a novel framework for meeting the needs of autistic people in healthcare settings
With @Autistic_Doc & @SueMcCowan1
Graphics by @LittlePuddins
Open access with @bjhospmed funded by @DoctorsAutistic leads team
https://t.co/Kt4mKhS0V7
Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-analysis of Randomized Trials https://t.co/Hzis6DKkgs
Reversing @BMA_JuniorDocs pay cuts means £14 ➡️ £19 for a first year doctor:
- 100k of student debt
- 5 years of med school
- Works 48hr/week as standard
- Nights, evenings, weekends
- Might first one to see you in A+E or first on the scene if your heart stops
#PayRestoration
"The public knows that the failings in the NHS aren’t the fault of this generation of doctors who face burnout, understaffing, stagnant pay, unsustainable debt, and a lack of career progression or opportunities to specialise" @parthaskar https://t.co/1UorLDbl8W
Tweeting on behalf of the newly formed UK Thrombosis Research Network - a group of thrombosis enthused clinicians and scientists who want to bring like minded folk together. Please read this thread for more info. @LaraNRoberts1 @bagot_catherine@ThrombosisUK
Reminder that the next @NUTHGrandRounds - Management of large DVT - will take place on Tuesday 14th Feb in CRB lecture theatre, RVI 12:30-13:30. Pizza from 12pm. All welcome. @NUTHMedEd@KateMusgrave@SandipNandhra
1 year results from XTEND1 study of efanesoctocog Alfa/BIV001 revealed improvement in joint health & BMI, particularly in older & higher joint score group #EAHAD2023#SLAM
Interesting talk on corticosteroids side effects and the risks of hypoadrenalism by M Gurnell raising many questions and highlighting the need of patient education on this area in particular with the advent of #GeneTherapy. #eahad2023
#EAHAD2023 . Mark Gurnel on a very insightful presentation on Dealing with steroid side effects and withdrawal. Good to hear a endocrinologist talk about this important safety issue in Gene Therapy
🆕 in @bmj_latest -
Rivaroxaban treatment for 6 weeks versus 3 months in patients with symptomatic isolated distal #DeepVeinThrombosis: randomised controlled trial
Congrats to Prof. Ageno & the RIDTS investigators! @INVENT_VTE
https://t.co/Htrp7FsOLJ